Table 3.
Key Reference Paper (Year), Country | Utility Score |
---|---|
Lang et al (2015), Hong Kong21 | |
Alive without permanent complication | 1 |
Alive with permanent complication | 0.54 |
Death | 0 |
Venkatesh et al (2017), USA22 | |
Disease-free state after lobectomy without complication | 0.99 |
Disease-free state after operation and RAI | 0.95 |
Disease-free state after lobectomy with short-term complication | 0.75 |
Lobectomy | 0.74 |
RAI | 0.64 |
Disease-free state after lobectomy with long-term complication | 0.63 |
Redo LND | 0.56 |
TTLND | 0.55 |
TTLND with complication | 0.54 |
Disease recurrence | 0.54 |
Redo LND with complication | 0.41 |
Disutility difference of AS compared to disease-free state post-lobectomy without complication | 0.11 |
White et al (2020), USA24 | |
Hypoparathyroidism | 0.836 |
Hypothyroidism | 0.83 |
Unilateral RLN injury | 0.627 |
Cancer recurrence | 0.54 |
Distant metastatic disease | 0.25 |
Bilateral RLN injury | 0.205 |
Diagnosis | −0.04a |
FNA biopsy | −0.5 |
Hematoma during surgery | −0.5 |
Airway problem during surgery | −0.5 |
Patient baseline utilities | Variable |
Notes: aWhite et al24 estimated disutility and summed it into the patient’s total lifetime utility score.
Abbreviations: RLN, recurrent laryngeal nerve; FNA, fine needle aspiration; RAI, radioactive iodine; LND, lymph node dissection; TT, total thyroidectomy.